SIK1 and COVID-19: By analyzing changes in specific molecular and biochemical markers associated with muscle and bone physiology, the study seeks to identify predictive biomarkers and delineate potential pathways through which COVID-19 may contribute to MSK dysfunction, ultimately enabling the prediction of MSK pathology in affected individuals.